{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T13:10:32Z","timestamp":1678713032043},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s42000-019-00167-9","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T07:24:38Z","timestamp":1576913078000},"page":"223-232","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Salt intake in mineralocorticoid receptor antagonist-treated primary aldosteronism: foe or ally?"],"prefix":"10.1007","volume":"19","author":[{"given":"Stelios","family":"Fountoulakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Labrini","family":"Papanastasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos","family":"Voulgaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Kounadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Piaditis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,21]]},"reference":[{"issue":"11","key":"167_CR1","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, PAPY Study Investigators (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48(11):2293\u20132300","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"167_CR2","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1210\/jc.2015-1268","volume":"100","author":"A Markou","year":"2015","unstructured":"Markou A, Sertedaki A, Kaltsas G, Androulakis II, Marakaki C, Pappa T, Gouli A, Papanastasiou L, Fountoulakis S, Zacharoulis A, Karavidas A, Ragkou D, Charmandari E, Chrousos GP, Piaditis GP (2015) Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension. J Clin Endocrinol Metab 100(8):2857\u20132864. https:\/\/doi.org\/10.1210\/jc.2015-1268","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"167_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/eci.12286","volume":"44","author":"L Papanastasiou","year":"2014","unstructured":"Papanastasiou L, Markou A, Pappa T, Gouli A, Tsounas P, Fountoulakis S, Kounadi T, Tsiama V, Dasou A, Gryparis A, Samara C, Zografos G, Kaltsas G, Chrousos G, Piaditis G (2014) Primary aldosteronism in hypertensive patients: clinical implications and target therapy. Eur J Clin Investig 44(8):697\u2013706. https:\/\/doi.org\/10.1111\/eci.12286","journal-title":"Eur J Clin Investig"},{"issue":"8","key":"167_CR4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiology 45(8):1243\u20131248. https:\/\/doi.org\/10.1016\/j.jacc.2005.01.015","journal-title":"J Am Coll Cardiology"},{"issue":"1","key":"167_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6(1):41\u201350. https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"167_CR6","first-page":"756","volume":"48","author":"PO Lim","year":"1999","unstructured":"Lim PO, Jung RT, MacDonald TM (1999) Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Br J ClinPharmacol 48(5):756\u2013760","journal-title":"Br J ClinPharmacol"},{"key":"167_CR7","doi-asserted-by":"publisher","unstructured":"Parthasarathy HK, Menard J, White WB, Young WF, Jr., Williams GH, Williams B, Ruilope LM, McInnes GT, Connell JM, MacDonald TM. A (2011) A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens 29(5):980\u2013990. https:\/\/doi.org\/10.1097\/HJH.0b013e3283455ca5","DOI":"10.1097\/HJH.0b013e3283455ca5"},{"issue":"7","key":"167_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/ndt\/gft052","volume":"28","author":"JW Funder","year":"2013","unstructured":"Funder JW (2013) Primary aldosteronism and low renin hypertension: a continuum? Nephrol Dial Transplant 28(7):1625\u20131627. https:\/\/doi.org\/10.1093\/ndt\/gft052","journal-title":"Nephrol Dial Transplant"},{"key":"167_CR9","doi-asserted-by":"publisher","unstructured":"Karagiannis A, Tziomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, Anagnostis P, Athyros VG, Mikhailidis DP (2008) Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert OpinPharmacother9(4):509\u2013515. https:\/\/doi.org\/10.1517\/14656566.9.4.509","DOI":"10.1517\/14656566.9.4.509"},{"issue":"10","key":"167_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/jhh.2017.38","volume":"31","author":"N Wada","year":"2017","unstructured":"Wada N, Shibayama Y, Umakoshi H, Ichijo T, Fujii Y, Kamemura K, Kai T, Sakamoto R, Ogo A, Matsuda Y, Fukuoka T, Tsuiki M, Suzuki T, Naruse M (2017) Hyperkalemia in both surgically and medically treated patients with primary aldosteronism. J Hum Hypertens 31(10):627\u2013632. https:\/\/doi.org\/10.1038\/jhh.2017.38","journal-title":"J Hum Hypertens"},{"issue":"16","key":"167_CR11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.108.807917","volume":"118","author":"A Desai","year":"2008","unstructured":"Desai A (2008) Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit. Circulation 118(16):1609\u20131611. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.807917","journal-title":"Circulation"},{"issue":"2","key":"167_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","volume":"20","author":"JS Williams","year":"2006","unstructured":"Williams JS, Williams GH, Raji A, Jeunemaitre X, Brown NJ, Hopkins PN, Conlin PR (2006) Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens 20(2):129\u2013136. https:\/\/doi.org\/10.1038\/sj.jhh.1001948","journal-title":"J Hum Hypertens"},{"issue":"11","key":"167_CR13","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1681\/ASN.2009101077","volume":"21","author":"BM Christensen","year":"2010","unstructured":"Christensen BM, Perrier R, Wang Q, Zuber AM, Maillard M, Mordasini D, Malsure S, Ronzaud C, StehleJC RBC, Hummler E (2010) Sodium and potassium balance depends on \u03b1ENaC expression in connecting tubule. J Am Soc Nephrol 21(11):1942\u20131951. https:\/\/doi.org\/10.1681\/ASN.2009101077","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"167_CR14","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1681\/ASN.2015020154","volume":"27","author":"R Perrier","year":"2016","unstructured":"Perrier R, Boscardin E, Malsure S, Sergi C, Maillard MP, Loffing J, Loffing-Cueni D, S\u00f8rensen MV, Koesters R, Rossier BC, Frateschi S, Hummler E (2016) Severe salt-losing syndrome and hyperkalemia induced by adult nephron-specific knockout of the epithelial sodium channel \u03b1-subunit. J Am Soc Nephrol 27(8):2309\u20132318. https:\/\/doi.org\/10.1681\/ASN.2015020154","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"167_CR15","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1210\/jc.2012-3353","volume":"98","author":"A Markou","year":"2013","unstructured":"Markou A, Pappa T, Kaltsas G, Gouli A, Mitsakis K, Tsounas P, Prevoli A, Tsiavos V, Papanastasiou L, Zografos G, Chrousos GP, Piaditis GP (2013) Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension. J Clin Endocrinol Metab 98(4):1409\u20131416. https:\/\/doi.org\/10.1210\/jc.2012-3353","journal-title":"J Clin Endocrinol Metab"},{"issue":"25 Suppl 2","key":"167_CR16","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1161\/01.cir.0000437740.48606.d1","volume":"129","author":"RH Eckel","year":"2014","unstructured":"Eckel RH, JakicicJM AJD, de Jesus JM, Houston Miller N, Hubbard VS, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith SC Jr, Svetkey LP, Wadden TA, Yanovski SZ, Kendall KA, Morgan LC, Trisolini MG, Velasco G, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF (2014) American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. Circulation 129(25 Suppl 2):S76\u2013S99. https:\/\/doi.org\/10.1161\/01.cir.0000437740.48606.d1","journal-title":"Circulation"},{"key":"167_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cca.2013.10.012","volume":"432","author":"A Dolci","year":"2014","unstructured":"Dolci A, Panteghini M (2014) Harmonization of automated hemolysis index assessment and use: is it possible? Clin Chim Acta 432:38\u201343. https:\/\/doi.org\/10.1016\/j.cca.2013.10.012","journal-title":"Clin Chim Acta"},{"issue":"4","key":"167_CR18","doi-asserted-by":"publisher","first-page":"E417","DOI":"10.3390\/nu9040417","volume":"9","author":"E Vasara","year":"2017","unstructured":"Vasara E, Marakis G, Breda J, Skepastianos P, Hassapidou M, Kafatos A, Rodopaios N, Koulouri AA, Cappuccio FP (2017) Sodium and potassium intake in healthy adults in Thessaloniki Greater Metropolitan Area-The Salt Intake in Northern Greece (SING) Study. Nutrients 9(4):E417. https:\/\/doi.org\/10.3390\/nu9040417","journal-title":"Nutrients"},{"issue":"5","key":"167_CR19","doi-asserted-by":"publisher","first-page":"e005574","DOI":"10.1161\/JAHA.117.005574","volume":"6","author":"G Maiolino","year":"2017","unstructured":"Maiolino G, Rossitto G, Bisogni V, Cesari M, Seccia TM, Plebani M, Rossi GP, PAPY Study Investigators (2017) Quantitative Value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study. J Am Heart Assoc 6(5):e005574. https:\/\/doi.org\/10.1161\/JAHA.117.005574","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"167_CR20","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","volume":"28","author":"Y Ori","year":"2013","unstructured":"Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, Gafter U, Salman H (2013) Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low hypertension on low dose spironolactone. Nephrol Dial Transplant 28(7):1787\u20131793. https:\/\/doi.org\/10.1093\/ndt\/gfs587","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"167_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","volume":"2","author":"S Bansal","year":"2009","unstructured":"Bansal S, Lindenfeld J, Schrier RW (2009) Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2(4):370\u2013376. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.108.821199","journal-title":"Circ Heart Fail"},{"issue":"1","key":"167_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2017","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2017) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endrocrinol 6(1):51\u201359. https:\/\/doi.org\/10.1016\/S2213-8587(17)30367-4","journal-title":"Lancet Diabetes Endrocrinol"},{"issue":"3","key":"167_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2215\/CJN.07821109","volume":"5","author":"MR Weir","year":"2010","unstructured":"Weir MR, Rolfe M (2010) Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am SocNephrol 5(3):531\u2013548. https:\/\/doi.org\/10.2215\/CJN.07821109","journal-title":"Clin J Am SocNephrol"},{"issue":"6","key":"167_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1056\/NEJMoa040135","volume":"351","author":"DN Juurlink","year":"2004","unstructured":"Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 351(6):543\u2013551","journal-title":"N Engl J Med"},{"issue":"4","key":"167_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCHEARTFAILURE","volume":"7","author":"O Vardeny","year":"2014","unstructured":"Vardeny O, Claggett B, Anand I, Rossignol P, Desai AS, Zannad F, Pitt B, Solomon SD (2014) Randomized Aldactone evaluation study (RALES) investigators. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Circ Heart Fail 7(4):573\u2013579. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE","journal-title":"Circ Heart Fail"},{"issue":"5","key":"167_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000237742","volume":"30","author":"N Khosla","year":"2009","unstructured":"Khosla N, Kalaitzidis R, Bakris GL (2009) Predictors of hyperkalemia risk following hypertension control with aldosterone blockade. Am J Nephrol 30(5):418\u2013424. https:\/\/doi.org\/10.1159\/000237742","journal-title":"Am J Nephrol"},{"issue":"1","key":"167_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijcard.2014.09.091","volume":"177","author":"F Pelliccia","year":"2014","unstructured":"Pelliccia F, Patti G, Rosano G, Greco C, Gaudio C (2014) Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: systematic review and meta-analysis. Int J Cardiol 177(1):219\u2013228. https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.091","journal-title":"Int J Cardiol"},{"issue":"17","key":"167_CR28","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jacc.2013.04.086","volume":"62","author":"R Eschalier","year":"2013","unstructured":"Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, PocockSJ SH, Vincent J, Rossignol P, Zannad F, Pitt B (2013) Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and\/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure). J Am Coll Cardiol 62(17):1585\u20131593. https:\/\/doi.org\/10.1016\/j.jacc.2013.04.086","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"167_CR29","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","volume":"118","author":"B Pitt","year":"2008","unstructured":"Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R (2008) Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation 118(16):1643\u20131650. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.778811","journal-title":"Circulation"},{"issue":"3","key":"167_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00424-011-1062-y","volume":"463","author":"L Lai","year":"2012","unstructured":"Lai L, Feng X, Liu D, Chen J, Zhang Y, Niu B, Gu Y, Cai H (2012) Dietary salt modulates the sodium chloride cotransporter expression likely through an aldosterone-mediated WNK4-ERK1\/2 signaling pathway. Pflugers Arch 463(3):477\u2013485. https:\/\/doi.org\/10.1007\/s00424-011-1062-y","journal-title":"Pflugers Arch"},{"issue":"8","key":"167_CR31","doi-asserted-by":"publisher","first-page":"F1139","DOI":"10.1152\/ajprenal.00259.2013","volume":"305","author":"IM Schiessl","year":"2013","unstructured":"Schiessl IM, Rosenauer A, Kattler V, Minuth WW, Oppermann M, Castrop H (2013) Dietary salt intake modulates differential splicing of the Na-K-2ClcotransporterNKCC2. Am J Physiol Renal Physiol 305(8):F1139\u2013F1148. https:\/\/doi.org\/10.1152\/ajprenal.00259.2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10043","key":"167_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0140-6736(16)30467-6","volume":"388","author":"A Mente","year":"2016","unstructured":"Mente A, O'Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Li W, Lu Y, Yi S, Rensheng L, Iqbal R, Mony P, Yusuf R, Yusoff K, Szuba A, Oguz A, Rosengren A, Bahonar A, Yusufali A, Schutte AE, Chifamba J, Mann JF, Anand SS, Teo K, Yusuf S, PURE, EPIDREAM and ONTARGET\/TRANSCEND Investigators (2016) Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet 388(10043):465\u2013475. https:\/\/doi.org\/10.1016\/S0140-6736(16)30467-6","journal-title":"Lancet"},{"key":"167_CR33","doi-asserted-by":"publisher","first-page":"f1326","DOI":"10.1136\/bmj.f1326","volume":"346","author":"NJ Aburto","year":"2013","unstructured":"Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ (2013) Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ 346:f1326. https:\/\/doi.org\/10.1136\/bmj.f1326","journal-title":"BMJ"},{"issue":"7041","key":"167_CR34","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/bmj.312.7041.1249","volume":"312","author":"P Elliott","year":"1996","unstructured":"Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M (1996) Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ 312(7041):1249\u20131253","journal-title":"BMJ"},{"issue":"28","key":"167_CR35","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, TamargoJL TM, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, HitijJB CM, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Ryd\u00e9n L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA (2013) ESH\/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159\u20132219. https:\/\/doi.org\/10.1093\/eurheartj\/eht151","journal-title":"Eur Heart J"},{"issue":"22","key":"167_CR36","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.1161\/CIR.0000000000000462","volume":"134","author":"M Vos","year":"2016","unstructured":"Vos M, Wylie-Rosett J, Kris-Etherton P (2016) American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Stroke Council. Recommended Dietary Pattern to Achieve Adherence to the American Heart Association\/American College of Cardiology (AHA\/ACC) Guidelines: a Scientific Statement From the American Heart Association. Circulation 134(22):e505\u2013e529. https:\/\/doi.org\/10.1161\/CIR.0000000000000462","journal-title":"Circulation"},{"issue":"5","key":"167_CR37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/HJH.0000000000000870","volume":"34","author":"L Ghazi","year":"2016","unstructured":"Ghazi L, Dudenbostel T, Lin CP, Oparil S, Calhoun DA (2016) Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status. J Hypertens 34(5):1005\u20131010. https:\/\/doi.org\/10.1097\/HJH.0000000000000870","journal-title":"J Hypertens"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-019-00167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-019-00167-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-019-00167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,20]],"date-time":"2020-12-20T00:42:10Z","timestamp":1608424930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s42000-019-00167-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,21]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1007\/s42000-019-00167-9","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,21]]},"assertion":[{"value":"22 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed were in accordance with the ethical standards of General Hospital of Athens \u2018G. Gennimatas\u2019 research committee and with the 1964 Helsinki declaration and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}